AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2015
Jun 23, 2015
35323_dirs_2015-06-23_1b678581-11b6-4466-88cf-2afc4590db91.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2015-06-19
Reporting Person: HOLLIMAN JOHN M III (Director, Executive Chairman)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-19 | Stock Option (Right to Buy) | $0.25 | A | 50000 | Acquired | 2025-06-19 | Common Stock (50000) | Direct |
| 2015-06-19 | Stock Option (Right to Buy) | $0.25 | A | 200000 | Acquired | 2025-06-19 | Common Stock (200000) | Direct |
Footnotes
F1: 50% immediately vested and 50% to vest monthly over 12 month-period
More from Capstone Holding Corp.
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Apr 23
Annual Report
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Apr 16